Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from STAB

‘It sucks, man’: World Surf League’s dreaded cut claims its final unlucky victims

The controversial feature, added in 2022, will disappear after the Margaret River Pro. Few surfers on the elite tour are sad to see it go

The Guardian - AU · May 21, 2025

Woman Sues Restaurant For Kicking Her Out Over “Revealing” Outfit While Other Customers Dressed Similarly

Black woman who was kicked out of restaurant over her outfit is now suing the establishment.

Bored Panda · Apr 25, 2025

‘Utterly humiliated’ customer files suit against restaurant for giving her the boot over crop-top dress

Y’Mine McClanahan’s outfit did not fall under any of the specifically banned items listed in the online policy, she argues in her lawsuit

The Independent UK · Apr 22, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Surfing prodigy Milla Brown: ‘It’s pretty normal now for girls to be doing big airs’

The 17-year-old Australian matches her male counterparts in aerial ability and tube riding but is in no hurry to reach the WSL

The Guardian - AU · Feb 24, 2025

“We Have Buckled Down On Our Dress Code”: Woman Kicked Out Of Restaurant Over “Revealing” Outfit

"mortified, violated, ashamed, and really humiliated" The post “We Have Buckled Down On Our Dress Code”: Woman Kicked Out Of Restaurant Over “Revealing” Outfit first appeared on Bored Panda.

Bored Panda · Jul 26, 2024

Why Are Statera Biopharma Shares Surging Today

Statera Biopharma Inc (NASDAQ:STAB) has entered into a non-binding term sheet with Immune Therapeutics Inc (OTC:IMUN) to sell its naltrexone and met-enkephalin rights. The transaction is contingent upon the negotiation of a definitive agreement and satisfaction of several closing conditions, including a contingency on Immune Therapeutics financing. Under the anticipated terms, Statera will receive an…

Benzinga · Apr 28, 2022

Coeptis Therapeutics Intends To Acquire Statera's TLR5 Agonist Platform

Coeptis Therapeutics Inc (OTC:COEP) has entered into a strategic agreement with Statera Biopharma Inc (NASDAQ:STAB) that gives Coeptis the right to acquire Statera'stoll-like receptor 5 (TLR5) agonist platform, including entolimod. Coeptis will agree to pay Statera Biopharma $6 million and revenue-based milestone payments to be defined in the definitive agreement. TLR5 is an innate immunity…

Benzinga · Apr 13, 2022

Read news from The Economist, FT, and more,
with one subscription

Lost World: Ancient Underwater City Revealed

The city is located at the bottom of Lake Atitlan, in the Solola Department, near the town of Panajachel.

Zenger · Apr 6, 2022

24 Stocks Moving in Friday's Pre-Market Session

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19.

Benzinga · Mar 4, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.